UCTT Gives Back the Rally — Shorts Ease as the Tape Cracks

Short positioning tells a notably calmer story than the price action suggests. Short interest edged lower on the week, falling roughly 4% to 7.2% of the free float — about 3.3 million shares. That decline continues a gradual unwinding that began in mid-June, when SI was running near 8.3% of float. The borrow market remains loose. Availability is running at 935%, meaning for every share currently borrowed there are roughly nine more available to lend. Cost to borrow has picked up — rising 45% over the past week to 0.55% — but that remains firmly in "easy borrow" territory. The lending market is not the story here. Options positioning has also unwound the defensiveness flagged in last week's note: the put/call ratio has dropped back to 0.15, well below its 20-day average of 0.19, indicating traders are no longer aggressively hedging downside. If anything, options flow looks more complacent than cautious given the magnitude of the selloff.

The Street was broadly constructive heading into this move, though the most recent analyst data is now four weeks old. Oppenheimer raised its target to $115 in early June while maintaining Outperform. UBS initiated at Buy with a $130 target in early May. TD Cowen and Needham both raised targets to $100 and $92 respectively after Q1 results in late April. The consensus mean target was $107.40 — now sitting roughly 18% above the current price, though that gap will almost certainly narrow as analysts update post-selloff. The bull case centres on UCTT's high-margin service business, OEM partnerships, and China exposure. Bears point to the stock's near-total dependence on semiconductor capex cycles and a margin structure that has widened on volume rather than mix improvement. EPS momentum remains strong on a 30-day basis (89th percentile) and a 90-day basis (82nd percentile), but those readings predate whatever has driven this week's selling.

Insider activity adds a layer of context. The Chief Accounting Officer sold approximately $494,000 worth of stock on July 2 at prices between $127 and $130 — well above where the stock trades today. The CFO sold a combined $511,000 in early June around $87-$92, which now looks prescient. Neither sale was large enough to be alarming on its own, and both appear to be routine scheduled disposals. The 90-day net insider figure is actually a net positive at roughly $2.76 million, reflecting earlier purchases that predate the recent activity. Still, the timing of the CAO sales — executed at what turned out to be near the peak — will attract attention.

Q2 earnings are scheduled for July 24. The last two prints produced moves of +8.5% and -11.2% on the day, with the five-day drift subsequently moderate in both directions. With the stock now having given back the entire post-Q1 rally and more, the July 24 print becomes the next clear focus — the question is whether the selloff has already discounted whatever the market fears, or whether guidance will set a new tone for the second half.